ChemAbout
© 2026 ChemAbout
İçgörüler|Gizlilik Politikası|Kullanım Koşulları|[email protected]
Ana Sayfa/Bileşikler/Aktif Farmasötik İngredient/Cortrosyn
C136H210N40O31S
2933.4 g/mol
Aktif Farmasötik İngredientTehlike

Cortrosyn

CAS16960-16-0EC241-031-1
Kategori
Aktif Farmasötik İngredient
Bileşik Sınıfı
Peptit
Birincil Kullanım
Farmasötik ham madde

Cortrosyn is a synthetic peptide compound used as a diagnostic aid for assessing adrenal function. It serves as a pharmaceutical raw material in the manufacturing of diagnostic agents for adrenal insufficiency testing.

pharmaceutical raw material for diagnostic agentscompound used in adrenal function assessment

İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.

Bu bileşiği tedarik ediyor veya sağlıyor musunuz?

Envanterinizi listeleyin veya satın alma talebi gönderin

CAS 16960-16-0

Bu Ürünü Listele
Tedarik bilgisi yayınlamak için oturum açın
Bu Ürünü Talep Et
Kayıt olmadan talep gönderin

İlgili Bileşikler

GüçlüBenzer yapıBenzerlik 0.99

(D-Lys16)-ACTH (1-24) (human, bovine, rat) trifluoroacetate salt

CAS494750-52-6

research reagent for receptor studies

GüçlüBenzer yapıBenzerlik 0.97

Endo-4a-Glu-ACTH (1-24) (human, bovine, rat)

CAS1815618-18-8

Research reagent for ACTH studies

ReferansAynı kategori

(S)-1-(4-(6-chloro-8-fluoro-7-(2-fluoro-6-hydroxyphenyl)quinazolin-4-yl)piperazin-1-yl)prop-2-en-1-one

CAS1698024-73-5

covalent KRAS-G12C inhibitor

ReferansAynı kategori

(S)-1-(4-(6-chloro-8-fluoro-7-(2-fluoro-6-hydroxyphenyl)quinazolin-4-yl)piperazin-1-yl)prop-2-en-1-one

CAS1698055-85-4

covalent KRAS-G12C inhibitor

ReferansAynı kategori

(S)-1-(4-(6-chloro-8-fluoro-7-(2-fluoro-6-hydroxyphenyl)quinazolin-4-yl)piperazin-1-yl)prop-2-en-1-one

CAS1698055-86-5

covalent KRAS-G12C inhibitor

ReferansAynı kategori

Exatecan mesilate

CAS169869-90-3

topoisomerase I inhibitor antineoplastic agent

Referansstereoisomer of

(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[2-[[(2S)-2-[[(2S)-1-[(2S)-6-amino-2-[[2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-amino-3-hydroxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylsulfanylbutanoyl]amino]-4-carboxybutanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]acetyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]acetyl]amino]hexanoyl]amino]hexanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]hexanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carboxylic acid;2,2,2-trifluoroacetic acid

CAS26469-81-8

active pharmaceutical ingredient

Referansstereoisomer of

Tetracosactrin acetate

CAS60189-34-6

active pharmaceutical ingredient

Güvenlik Referansı

Zararlı
Zararlı
Sağlık Tehlikesi
Sağlık Tehlikesi
Tehlike
H317May cause an allergic skin reaction
H332Harmful if inhaled
H334May cause allergy or asthma symptoms or breathing difficulties if inhaled
Tanımlayıcılar
IUPAC Adı

(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-1-[(2R)-2-[[(2R)-2-[[(2R)-6-amino-2-[[(2R)-6-amino-2-[[2-[[(2S)-2-[[(2S)-1-[(2S)-6-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[(2-amino-3-hydroxypropanoyl)amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylsulfanylbutanoyl]amino]-4-carboxybutanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]acetyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]acetyl]amino]hexanoyl]amino]hexanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]hexanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carboxylic acid

InChIKey

ZOEFCCMDUURGSE-CQVUSSRSSA-N

SMILES

CC(C)[C@@H](C(=O)NCC(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N3CCC[C@H]3C(=O)O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC5=CNC6=CC=CC=C65)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC7=CC=CC=C7)NC(=O)[C@H](CC8=CNC=N8)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](CC9=CC=C(C=C9)O)NC(=O)C(CO)N

Eş Anlamlılar (36)
  • Cosyntropin (USP)
  • 1-24-ACTH
  • 1-24-Corticotropin
  • ACTH (1-24)
  • ATCH (1-24)
  • Acth,
  • Acthalpha(1-24)
  • Actholain
  • Ba 30920
  • Ba 36716
  • Corticotropin (1-24)-Peptide
  • Corticotropin-(1-24)
  • Cortrosyn
  • Cortrosyn (TN)
  • Synacthen
  • Synthetic ACTH
  • Tetracosactid
  • Tetracosactida
  • Tetracosactide
  • Tetracosactide acetate
  • Tetracosactide hexacetate
  • Tetracosactidum
  • Tetracosactrin
  • Tetracosapeptide
  • Vicotrope
  • alpha(1-24)-corticotrophin
  • beta(1-24)-Tetracosactide
  • beta(1-24)-corticotrophin
  • tetracosactide for bioassay
  • tetracosactrin zinc